Send mail to Author

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program (Article)

Please indicate your contact information and select, which author you want to contact.



 
            ______    _  _      ___     _    _    _    _   
    ___    /_   _//  | \| ||   / _ \\  | || | || | || | || 
   /   ||   -| ||-   |  ' ||  | / \ || | || | || | || | || 
  | [] ||   _| ||_   | .  ||  | \_/ || | \\_/ || | \\_/ || 
   \__ ||  /_____//  |_|\_||   \___//   \____//   \____//  
    -|_||  `-----`   `-` -`    `---`     `---`     `---`   
     `-`
 


Back to frontdoor view

OPUS4 Logo